These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 926093)

  • 21. Immune response to inactivated syngeneic mammary adenocarcinoma cells. II. Parameters of immunogenicity in DBA/2 mice.
    DeLustro F; Haskill JS
    J Natl Cancer Inst; 1980 Jan; 64(1):131-7. PubMed ID: 6928038
    [No Abstract]   [Full Text] [Related]  

  • 22. Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy.
    Norris S; Doherty DG; Curry M; McEntee G; Traynor O; Hegarty JE; O'Farrelly C
    Cancer Immunol Immunother; 2003 Jan; 52(1):53-8. PubMed ID: 12536240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody-dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin 2.
    Shiloni E; Eisenthal A; Sachs D; Rosenberg SA
    J Immunol; 1987 Mar; 138(6):1992-8. PubMed ID: 3493293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alloantigen-activated lymphocytes from mice bearing a spontaneous "nonimmunogenic" adenocarcinoma inhibit its growth in vivo by recruiting host immunoreactivity.
    Giovarelli M; Santoni A; Forni G
    J Immunol; 1985 Nov; 135(5):3596-603. PubMed ID: 3930610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
    Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibody to a human salivary gland adenocarcinoma cell line: augmentation of antibody-dependent cell-mediated cytotoxicity activity by streptococcal preparation OK-432 in human salivary gland adenocarcinoma-bearing nude mice given the antibody.
    Kaji R; Yoshida H; Yanagawa T; Sato M
    J Biol Response Mod; 1989 Oct; 8(5):488-500. PubMed ID: 2552025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Natural cytotoxic cells (NK) and their role in the immunological control of neoplasms].
    Rupniewska ZM; Adamczyk MB
    Postepy Hig Med Dosw; 1981; 35(1):37-52. PubMed ID: 6174960
    [No Abstract]   [Full Text] [Related]  

  • 28. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
    Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
    J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phorbol esters enhance spontaneous cytotoxicity of human lymphocytes, abrogate Fc receptor expression, and inhibit antibody-dependent lymphocyte-mediated cytotoxicity.
    Trinchieri G; O'Brien T; Shade M; Perussia B
    J Immunol; 1984 Oct; 133(4):1869-77. PubMed ID: 6432902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.
    Fujiwara H; Yoshioka T; Shima J; Kosugi A; Itoh K; Hamaoka T
    J Immunol; 1986 Apr; 136(7):2715-9. PubMed ID: 3005417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-associated cytotoxicity of autoantibodies in sera from rats with chemically induced hepatomas.
    Lando P; Blomberg F; Berzins K; Perlmann P
    Cancer Res; 1980 May; 40(5):1691-8. PubMed ID: 6768452
    [No Abstract]   [Full Text] [Related]  

  • 32. A tumour-associated membrane antigen transiently expressed by normal cells during mitosis.
    Bertini M; Forni G; Comoglio PM
    Clin Exp Immunol; 1974 Sep; 18(1):101-8. PubMed ID: 4468189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human T cells targeted with anti-T3 cross-linked to antitumor antibody prevent tumor growth in nude mice.
    Titus JA; Garrido MA; Hecht TT; Winkler DF; Wunderlich JR; Segal DM
    J Immunol; 1987 Jun; 138(11):4018-22. PubMed ID: 3108382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of N(G)-Nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, on IL-2-induced LAK cell generation in vivo and in vitro in healthy and tumor-bearing mice.
    Orucevic A; Lala PK
    Cell Immunol; 1996 Apr; 169(1):125-32. PubMed ID: 8612285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors.
    Kawamura K; Bahar R; Natsume W; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2002 Jan; 9(1):109-15. PubMed ID: 11916240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lectin-dependent cell-mediated cytotoxicity: assessment of cytotoxic reactivity following challenge with syngeneic tumors.
    Laux DC; Parker BM; DiSciullo SO; Petrarca MA; McAllister CG
    J Natl Cancer Inst; 1984 Mar; 72(3):667-72. PubMed ID: 6583449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune responsiveness to a murine mammary carcinoma modified to express B7-1, interleukin-12, or GM-CSF.
    Aruga E; Aruga A; Arca MJ; Lee WM; Yang NS; Smith JW; Chang AE
    Cancer Gene Ther; 1997; 4(3):157-66. PubMed ID: 9171934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic and in situ natural killer activity in transplanted and spontaneous mammary tumors in C3H/HeN mice.
    Gerson JM; Tagliabue A; Herberman RB
    J Reticuloendothel Soc; 1981 Jan; 29(1):15-21. PubMed ID: 7205815
    [No Abstract]   [Full Text] [Related]  

  • 39. Transplantability and antigenicity of two sublines of the TA3 tumor.
    Sanford BH; Codington JF; Jeanloz RW; Palmer PD
    J Immunol; 1973 May; 110(5):1233-7. PubMed ID: 4572632
    [No Abstract]   [Full Text] [Related]  

  • 40. Tumor-specific antigens as altered growth factor receptors.
    Prehn RT
    Cancer Res; 1989 Jun; 49(11):2823-6. PubMed ID: 2720642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.